Globe Newswire
Dublin, April 22, 2021 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Therapies Market: Focus on Commercialized Therapies, Pipeline Therapies, Type of Virus, Application, Region (15 Countries), and Competitive Landscape - Analysis and Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering. Global Oncolytic Virus Therapies Market to Reach $962.0 Million by 2030 Oncolytic virus therapies to be one of the most rapidly evolving technologies, and the global market is predicted to grow at a CAGR of 26.28% over the forecast period 2020-2030. Market OverviewOncolytic virus therapies are overlapping biomedical research fields with similar therapeutic goals, which target DNA or RNA inside or outside the body. These therapies aim at modifying genetic material for the treatment of a disease. Oncolytic virotherapy is a form of gene therapy that used nature's material (virus) to find and destroy malignant cells. Oncolytic virus therapy is "a novel approach to treat, cure, or ultimately prevent disease by changing the expression of a person's genes". Oncolytic virotherapy is a form of gene therapy that used nature's material (virus) to find and destroy malignant cells.Factors fueling the growth of the market include prevalence of cancer, rising number of clinical trials, boosting research funding, and adoption of inorganic growth. Despite rapid advanced industry growth, there are several key issues that need to be addressed to facilitate future growth such as the relatively high total costs of therapies and lacking therapy-specific assay. Further, some of the opportunities such as clinical pipeline of therapies provide growth to the market.Within the research report, the market has been segmented on the basis of commercialized therapies, pipeline therapies, type of virus, application, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.Competitive LandscapeThe exponential rise in the cases of cancer on the global level has created a buzz among companies to invest in the therapeutics of advanced technologies. Due to a large number of pipeline therapies and intense market penetration, oncolytic virus therapies have been pioneers in the therapeutic field and have significant competitors in this market.Based on region, North America held the largest share in 2020, owing to improved healthcare infrastructure, rise in per capita income, and improvised reimbursement policies in the region. Apart from this, Europe and the Asia-Pacific are anticipated to grow at the fastest CAGR during the forecast period. Key Questions Answered in this Report: What are the major market drivers, challenges, and opportunities in the global oncolytic virus therapies market?What are the key development strategies being implemented by the major players in order to sustain in the competitive market?What are the key regulatory implications in developed and developing regions for the global oncolytic virus therapies market?How is each segment of the market expected to grow during the forecast period 2020-2030?Who are the leading players with significant offerings to the global oncolytic virus therapies market, and what is the expected market dominance for each of these leading players?What are the adoption trends for oncolytic virus therapies in established economies and emerging economies across the world?What is the COVID-19 impact on the global oncolytic virus therapies market?Which companies are anticipated to be highly disruptive in the future, and why?What are the unmet needs that are yet to be met by the global oncolytic virus therapies with respect to the application areas?What are the dynamics of various application areas and countries, which are impacting the global oncolytic virus therapies market?What are the new market opportunities of various technologies that are influencing the growth of the global oncolytic virus therapies market?How is each segment of the market expected to grow during the forecast period 2020-2030? The following are the segment types: Commercialized TherapiesPipeline TherapiesType of VirusApplicationRegion Key Topics Covered: 1 Product Definition1.1 Inclusion and Exclusion2 Market Scope2.1 Scope of Work2.2 Key Questions Answered in the Report3 Research Methodology3.1 Global Oncolytic Virus Therapies Market: Research Methodology3.2 Primary Data Sources3.3 Secondary Data Sources3.4 Market Estimation Model3.5 Criteria for Company Profiling4 Market Overview4.1 Market Definition4.2 Importance of Oncolytic Virus Therapies in Cancer Treatment4.3 Market Size and Growth Potential, $Million, 2019-20304.4 COVID-19 Impact on the Global Oncolytic Virus Therapies Market5 Industry Insights5.1 Overview5.2 Regulatory Scenario5.3 Legal Requirements and Framework in the U.S5.3.1 Clinical Trial Authorization5.3.2 U.S. FDA Guidelines for BLA Submission5.4 Legal Requirements and Framework in Europe5.4.1 EMA Biologics License Application Process5.4.2 Centralized Procedure5.4.3 Decentralized Procedure5.4.4 Mutual-Recognition Procedure5.5 Legal Requirements and Framework in Asia-Pacific5.5.1 China5.5.2 Japan5.6 Expedited Regulatory Designations Around the World5.7 Reimbursement Scenario5.8 Patent Analysis5.8.1 Patent Filing Trend6 Market Dynamics6.1 Overview6.2 Impact Analysis6.3 Market Drivers6.3.1 Increasing Incidence of Cancer6.3.2 Rising Number of Clinical Trials6.3.3 Increasing Research Funding from National Cancer Institute6.3.4 Increasing Adoption of Inorganic Growth Strategies in the Market6.4 Market Restrains6.4.1 High Cost of Therapy6.4.2 Lack of Therapy-Specific Assays6.5 Market Opportunities6.5.1 Opportunities in the Emerging Economies6.5.2 Drug Approvals and Strong Pipeline of Oncolytic Virus Therapies7 Competitive Landscape7.1 Synergistic Activities7.2 Business Expansion Activities and Others7.3 Product Launches and Product Updates7.4 Mergers and Acquisitions7.5 Market Share Analysis7.6 Growth Share Analysis7.6.1 Growth Share Analysis (by Commercialized Therapy)8 Oncolytic Virus Therapies: Epidemiology Analysis9 Global Oncolytic Virus Therapies Market (by Commercialized Therapies), $Million, 2019-20309.1 Overview9.2 Imlygic9.3 Oncorine9.4 RIGVIR10 Global Oncolytic Virus Therapies Market (by Pipeline Therapies), $Million, 2019-203010.1 Overview10.2 Phase I10.3 Phase II10.4 Phase III10.5 Phase IV11 Global Oncolytic Virus Therapies Market (by Type of Virus), $Million, 2019-203011.1 Overview11.2 Genetically Engineered Oncolytic Virus11.2.1 Herpes Simplex Virus (HSV)11.2.2 Adenovirus11.2.3 Vaccinia Virus11.3 Oncolytic Wild-Type Virus11.3.1 Reovirus (Respiratory Enteric Orphan Virus)11.3.2 Newcastle Disease Virus (NDV)11.3.3 Vesicular Stomatitis Virus (VSV)12 Global Oncolytic Virus Therapies Market (by Application), $Million, 2019-203012.1 Overview12.2 Solid Tumor12.2.1 Breast Cancer12.2.2 Prostate Cancer12.2.3 Lung Cancer12.2.4 Glioblastoma12.2.5 Melanoma12.2.6 Other Applications12.3 Hematological Malignancies12.3.1 Lymphoma12.3.2 Leukemia12.3.3 Myeloma13 Global Oncolytic Virus Therapies Market (by Region), $Million, 2019-203013.1 Overview14 Company Profiles Amgen Inc.DAIICHI SANKYO COMPANY, LIMITEDDNAtrixGeneluxOncolytics Biotech, Inc.PsiOxus TherapeuticsRIGVIR Ltd.Shanghai Sunway Biotech Co., Ltd.,SillaJen, Inc.Sorrento Therapeutics, Inc.Takara Bio Inc.Transgene saVCNBiosciencesViroCureViralytics Ltd. (Merck & Co., Inc.) For more information about this report visit https://www.researchandmarkets.com/r/i5dgst CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900